
INACTIVE/DISSOLVED
Address
MedImmune Ventures Inc
One MedImmune Way
Gaithersburg, MD 20878
United States
Phone
Website
VCID: 3030
Profile
Corporate information
Investment activity status
Not investing
Investments
Selected investments
Company | Country | Date | Notes | ||
---|---|---|---|---|---|
![]() |
Coferon Inc Develops orally active drugs that act like small drug molecules, can permeate cell membranes, and once inside, can assemble into larger molecules |
United States | 1 Jul 2012 | Series B |
|
![]() |
Catabasis Pharmaceuticals Inc |
United States | 1 Apr 2010 1 Dec 2011 |
Series A |
|
![]() |
Ambit Biosciences Inc A biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer. |
United States | 10 Jun 2011 | Series D |
|
![]() |
Rib-X Pharmaceuticals Inc |
United States | 1 Jan 2009 | N/A |
|
![]() |
Virdante Pharmaceuticals Inc A privately held biopharmaceutical company focused on the development and commercialization of drugs for autoimmune and inflammatory disorders. |
United States | 31 Dec 2008 | Series A |
|
![]() |
Arginetix Inc Biopharmaceutical company dedicated to developing and commercializing novel therapeutic small molecule inhibitors of arginase. |
United States | 1 Oct 2008 | Seed |
|
![]() |
BrainCells Inc A neurogenesis-based drug discovery and development company targeting novel therapies for mood disorders and other central nervous system diseases. |
United States | 1 Mar 2008 | Series B Active |
|
![]() |
VaxInnate Inc A biotechnology company, engages in the development and production of vaccines for pandemic and seasonal influenza diseases. |
United States | 25 Oct 2006 | Series C |
|
![]() |
Avidia Inc |
United States | 1 May 2005 | Series B Active |
|
![]() |
Iomai Corp Biopharmaceutical company focused on discovering and developing vaccines and immune system stimulants. |
United States | 31 Dec 2003 | Series C |
|
![]() |
VentiRx Pharmaceuticals Inc |
United States | N/A |
||
![]() |
Inotek Pharmaceuticals Corp Inotek Pharmaceuticals is a clinical-stage ophthalmic pharmaceutical company. |
United States | N/A |
||
![]() |
Cellective Therapeutics Inc |
United States | N/A |
||
![]() |
LigoCyte Pharmaceuticals Inc |
United States | N/A |
||
![]() |
Elusys Therapeutics Inc Develops antibody-based therapies to treat infectious diseases. |
United States | N/A |
||
![]() |
Applied Genetic Technologies Corp A gene therapy company that designs, packages and delivers therapeutic genes to treat a variety of medical illnesses using the adeno-associates virus. |
United States | N/A |
||
![]() |
Critical Therapeutics Inc Discoverer, developer and commercialize novel therapies. |
United States | N/A |
||
![]() |
Xencor Inc Provider of protein engineering technology platforms in the biotechnology industry. |
United States | N/A |
||
![]() |
Tercica Inc A biopharmaceutical company developing new therapeutics for endocrine system disorders. |
United States | N/A |